What change in practice, based on the all-cause mortality reduction reported in ODYSSEY Outcomes, do you believe is warranted, especially as these results might impact the LDL-C level that should be targeted and the duration of therapy?
Presenter
SAHMRI Deputy Director and Heart Foundation Heart Health Theme Leader
Professor of Cardiology
University of Adelaide
Consultant Cardiologist
Royal Adelaide Hospital
Adelaide, Australia